What Would Happen If China Faced a Fentanyl Crisis?
What Would Happen If China Faced a Fentanyl Crisis?
Fentanyl’s Test: What China’s Drug War Teaches America
By Carl J Chan
The fentanyl crisis in the United States has become a grim hallmark of modern public health failures, with devastating consequences that ripple through families, communities, and the nation’s social fabric. Imagining a similar crisis in China—a nation with a starkly different history, culture, and approach to drug control—offers a lens to examine not only the potential societal impact but also the structural and cultural factors that shape responses to such crises. By analyzing the U.S. fentanyl epidemic, China’s historical and contemporary drug control measures, and the cultural and legal contrasts between the two nations, we can explore how China might respond to a hypothetical fentanyl crisis and what lessons the U.S. might draw from China’s experience.
The U.S. Fentanyl Crisis: A Public Health Catastrophe
The United States has been grappling with an opioid epidemic that has evolved over decades, with fentanyl emerging as a central driver of overdose deaths since the early 2010s. According to the Centers for Disease Control and Prevention (CDC), drug overdose deaths in the U.S. rose from 49,860 in 2019 to 107,941 in 2022, before slightly declining to 105,007 in 2023. Synthetic opioids, primarily illicitly manufactured fentanyl (IMF), accounted for 72,776 of these deaths in 2023, representing nearly 70% of all overdose fatalities. Since 2018, over 250,000 Americans have died from fentanyl overdoses, with the drug claiming roughly 200 lives daily in 2022. Fentanyl’s potency—50 to 100 times stronger than morphine—makes it uniquely lethal, especially when mixed with other drugs like heroin, cocaine, or methamphetamine, often without users’ knowledge. The unpredictability of illicit drug purity exacerbates the risk, as even a dose as small as two milligrams can be fatal. One never knows what the ingredients of illegal drugs are and what their purity is!
The U.S. has pointed fingers at China as a key source of fentanyl precursors, chemicals used to manufacture the drug, which are often produced in Chinese labs and smuggled through Mexico by drug cartels. While China has taken steps to regulate these precursors—scheduling the entire class of fentanyl drugs in 2019 and additional precursors in 2024—the U.S. continues to press for stronger enforcement, viewing China’s role in the supply chain as a critical factor in the crisis. This accusation has strained U.S.-China relations, with China arguing that the U.S. must address its domestic demand and systemic issues rather than scapegoating foreign nations.
American Drug Culture and the Roots of the Crisis
The U.S. fentanyl crisis cannot be fully understood without examining the cultural and systemic factors that paved its way. American drug culture has long been shaped by a tension between individual freedom and societal control. The 1960s counterculture, epitomized by the hippie movement, celebrated experimentation with substances like marijuana, LSD, and heroin as acts of rebellion against conformity. While the hippies’ drug use was often framed as a pursuit of personal liberation, it normalized recreational drug use in ways that left lasting cultural imprints. This ethos of individual choice persists, complicating efforts to regulate drug use in a society that prizes personal autonomy.
The opioid epidemic’s first wave, beginning in the 1990s, was driven by pharmaceutical companies like Purdue Pharma, which aggressively marketed prescription painkillers such as OxyContin. These companies downplayed addiction risks, flooding communities with prescriptions—81.32 per 100 people in 2010, according to the CDC. This “painkiller culture” was bolstered by pervasive pharmaceutical advertising, unique to the U.S. among developed nations, which conditioned Americans to view medication as a quick fix for physical and emotional pain. The overprescription of opioids created a generation of dependent users, many of whom turned to heroin and fentanyl when prescriptions dried up after regulatory crackdowns around 2011. This shift marked the epidemic’s second and third waves, with fentanyl dominating since 2013 due to its potency and low cost.
The interplay of individual freedom, pharmaceutical greed, and lax oversight created a perfect storm. Unlike China, where state control shapes public behavior, the U.S.’s emphasis on personal choice and market-driven healthcare has hindered cohesive responses to the crisis, leaving communities vulnerable to the influx of illicit drugs.
China’s Historical and Contemporary War on Drugs
China’s relationship with drugs is deeply rooted in its history, particularly the Opium Wars of the 19th century, when British and other Western powers forced opium into China, leading to widespread addiction and social devastation. This historical trauma has shaped China’s aggressive stance on drug control, viewing narcotics as a threat to national sovereignty and social stability. In the 20th century, the Communist government eradicated opium use through mass campaigns, strict enforcement, and social mobilization, setting a precedent for its modern approach.
In the 1990s and 2000s, China faced a resurgence of drug use, particularly heroin, amid economic reforms and increased global connectivity. The government responded with a comprehensive “People’s War on Drugs,” blending propaganda, community engagement, and draconian measures. Public service announcements flooded television and radio, warning of drugs’ dangers. Schools integrated anti-drug education, and communities organized rallies in public squares to stigmatize drug use. Law enforcement was relentless, with public trials and harsh penalties, including executions for major traffickers, serving as deterrents. These measures, coupled with state-controlled media and a collectivist culture, significantly reduced drug use and trafficking by the early 2000s.
China’s success relied on its authoritarian framework, which allowed for swift, top-down interventions. Today, China maintains stringent drug laws, with over 1.5 million arrests for drug-related offenses between 2015 and 2020, according to state reports. While China has faced criticism for human rights concerns, its approach has kept domestic drug use low compared to the U.S., with opioid use disorders affecting less than 0.3% of the population versus 2-3% in the U.S.
A Hypothetical Fentanyl Crisis in China
If China were to face a fentanyl crisis, its response would likely mirror its historical and modern anti-drug campaigns, adapted to the unique challenges of fentanyl’s potency and global supply chains. The Chinese government would probably launch a multi-pronged offensive:
State-Led Crackdowns: China would intensify surveillance and policing of domestic labs and ports to curb precursor production and trafficking. Public trials of traffickers would reinforce deterrence, as seen in past campaigns. The government’s control over borders and internet commerce would limit the influx of illicit fentanyl, unlike the U.S., where porous borders and online markets complicate enforcement.
Mass Propaganda and Education: Public service announcements would saturate media, emphasizing fentanyl’s lethality and framing drug use as a betrayal of national values. Schools and workplaces would host mandatory anti-drug programs, leveraging China’s collectivist culture to stigmatize use. This contrasts with the U.S., where individualist messaging often undermines unified prevention efforts.
Community Mobilization: Local governments would organize rallies and community watch programs, encouraging citizens to report suspicious activity. This social cohesion, rooted in Confucian values of collective responsibility, would amplify enforcement efforts, unlike the U.S.’s fragmented community responses.
However, China would face challenges. Fentanyl’s global supply chain, involving countries like Mexico, could complicate enforcement, requiring international cooperation—a historically fraught area given U.S.-China tensions. Urbanization and social dislocation could also increase vulnerability to drug use, as seen in the 1990s heroin surge. Still, China’s authoritarian tools and cultural emphasis on collective welfare would likely contain the crisis more effectively than the U.S.’s decentralized approach.
Lessons from China and Cultural-Legal Challenges
China’s war on drugs offers lessons for the U.S., though cultural and legal differences pose significant hurdles:
Unified Messaging: China’s use of consistent, state-driven anti-drug campaigns contrasts with the U.S.’s mixed messages, where pharmaceutical ads and cultural tolerance for recreational drug use muddy prevention efforts. The U.S. could invest in nationwide public awareness campaigns, emphasizing fentanyl’s dangers and promoting harm reduction tools like naloxone, which has shown promise in reducing deaths.
Community Engagement: China’s mobilization of communities and schools highlights the power of social cohesion. The U.S. could strengthen community-based prevention, but its diverse, individualistic society resists top-down mandates, requiring localized, culturally sensitive approaches.
Strict Enforcement: China’s harsh penalties deter trafficking, but the U.S.’s legal system, grounded in due process and civil liberties, cannot adopt such measures without violating constitutional principles. Instead, the U.S. could enhance border security and target online drug markets, as seen in CBP’s Operation Hourglass, which seized over 1,484 pounds of fentanyl in early 2025.
Regulating Pharmaceuticals: China’s tight control over prescription drugs contrasts with the U.S.’s market-driven healthcare system. Reforming prescription practices and curbing pharmaceutical lobbying could reduce opioid misuse, but political resistance from industry stakeholders complicates change.
The U.S.’s emphasis on individual freedom fosters a drug culture that tolerates experimentation and resists heavy-handed regulation, unlike China’s collectivist ethos, which prioritizes social order. Legally, the U.S.’s decentralized governance and protections against state overreach limit the feasibility of China-style measures. These differences mean the U.S. must balance harm reduction, treatment access, and enforcement within its democratic framework, a challenge China’s authoritarian system sidesteps.
Conclusion
A fentanyl crisis in China would likely be met with swift, state-orchestrated action, leveraging historical anti-drug fervor, authoritarian control, and cultural collectivism to contain the epidemic. The U.S., mired in a crisis fueled by pharmaceutical greed, cultural permissiveness, and systemic gaps, can learn from China’s unified messaging and community engagement but must adapt these strategies to its democratic and individualistic context. The fentanyl crisis underscores the need for the U.S. to confront its painkiller culture, regulate pharmaceutical influence, and invest in prevention and treatment—without sacrificing the freedoms that define its society. Bridging these cultural and legal divides is the U.S.’s greatest challenge in turning the tide against fentanyl.
References
National Institute on Drug Abuse (NIDA), Drug Overdose Deaths: Facts and Figures, 2024.
Council on Foreign Relations, Fentanyl and the U.S. Opioid Epidemic, 2025. USAFacts, Are fentanyl overdose deaths rising in the US?, 2023.
Yale Medicine, Why Is Fentanyl Driving Overdose Deaths?, 2024.
CDC, Understanding the Opioid Overdose Epidemic, 2025.
NPR, 8 theories why fentanyl deaths are plummeting, 2025.
Brookings, The fentanyl pipeline and China’s role in the US opioid crisis, 2024.
SHADAC, The Opioid Epidemic in the United States, 2024.
Wikipedia, Opioid epidemic in the United States, 2025.
U.S. Customs and Border Protection, Frontline Against Fentanyl, 2025.
NPR, U.S. overdose deaths plummet, saving thousands of lives, 2024.